Related to Evotec Expands Screening Library with Addition of 110,000 ChemBridge Compounds

• Merck Launches Up To $430M Diabetes Collaboration with Abide
  
• Celgene, Concert in $300M+ Deuterium Drug Collaboration
  
• Nimbus, Shire Collaborate to Co-Develop Small Molecule Treatments
  
• Roche to Support Clinical Trials with Evotec’s Depression Therapy in $300M Deal
  
• Evotec Buys Summit’s Zebrafish Screening Business for Roughly $752K
  
• Evotec Earns Roughly $3.75M as Seventh Milestone Fee from Boehringer Ingelheim
  
• Boehringer Ingelheim Pledges $22.5M to Fund Another Four Years of Partnership with Evotec
  
• CHDI Pledges $37.5M in Research Funding Over the Next Three Years to Evotec
  
• Evotec Inks Anemia Drug Discovery Agreement with Vifor Pharma
  
• Evotec to Screen for Hits against Active Biotech Immune Disorder and Cancer Target
  
• Biogen Idec Taps Evotec for Hit-Identification Research
  
• Ono to Use Evotec’s Ion-Channel Drug Discovery Platform in Expanded Deal
  
• DiscoveRx Technologies to Support Evotec’s HTS Services
  
• Evotec Achieves €2M Milestone under Partnership with Boehringer Ingelheim
  
• Zhejiang Jingxin to Develop Evotec’s Clinical-Stage Insomnia Candidate in China
  
• Evotec and Merck KGaA Sign Neurological Drug Discovery Deal
  
• Lundbeck Signs Compound Management Agreement with BioFocus
  
• Hamilton Provides UNC with Integrated Compound Storage and Screening System
  
• Evotec Partners with Harvard and HHMI on Beta Cell Regeneration Approach to Diabetes
  
• Evotec and PsychoGenics Ally to Offer Integrated CNS Drug Discovery Solutions